]>
IRCT20230307057646N1 IRCT 2023-05-19 Esfahan University of Medical Sciences Comparing the outcomes pimecrolimus and mometasone cream in treatment of childhood vitiligo Comparing the outcomes of 1% pimecrolimus cream with 0.1% mometasone cream in treatment of childhood vitiligo in the face, neck and trunk 2023-07-06 anticipated 62 Complete https://irct.ir/trial/69097 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: 31 random numbers were generated using the random number generator function of the website calculator.net. the participants are numbered according to the order of addition to the study and the participants with the numbers mentioned before, will be assigned to the group with pimecrolimus as a treatment and others will be assigned to the mometasone group. 3 Vitiligo. Intervention 1: Intervention group: pimecrolimus 1% cream, topical use , twice a day for 2 months. Intervention 2: Intervention group: Mometasone 0.1% cream, topical use , daily. No - There is not a plan to make this available Justification or reason for not sharing IPD is the possible decline of cooperation by parents considering the cultural background
public Sarah Seyedyousefi
Student Research Committee, Isfahan University of Medical Sciences, hezarjarib avenue, Isfahan, Iran
Isfahan Iran (Islamic Republic of) 8174673461 +98 31 3630 5800 Sarah.syousefi@gmail.com Esfahan University of Medical Sciences scientific Sarah Seyedyousefi
Student Research Committee, Isfahan University of Medical Sciences, hezarjarib avenue, Isfahan, Iran
Isfahan Iran (Islamic Republic of) 8166755773 0098363305800 Sarah.syousefi@gmail.com Esfahan University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) Vitiligo in less than 10 percent of body surface non-segmental vitiligo no history of allergic reaction to used drugs no limit 18 years Both pregnancy and lactating using other treatments for vitiligo lesions in last 6 months severe allergic reactions to used drugs L80 Vitiligo Treatment - Drugs Treatment - Drugs Intervention group: pimecrolimus 1% cream, topical use , twice a day for 2 months Intervention group: Mometasone 0.1% cream, topical use , daily Visual Analogue Scale score of improvement according to the patients. Timepoint: 3 months after the initiation of the treatments. Method of measurement: patients score the improvement from 1-10. Mean changes in lesions size. Timepoint: 2 and 3 months after the initiation of the treatment. Method of measurement: millimeter sensitive ruler. Pigmentation improvement in the lesions according to 2 experts. Timepoint: 2 and 3 months after the initiation of the treatment. Method of measurement: 2 experts in dermatology scoring the improvement from 0 to 3. Esfahan University of Medical Sciences Approved 2023-03-06 Ethics committee of Isfahan University of Medical Sciences Ethics Committee of Isfahan university of medical sciences , Isfahan university of medical sciences, hezar jarib avenue, Isfahan, Iran Isfahan Isfehan Iran (Islamic Republic of)